Immediate Impact
55 standout
Citing Papers
MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future
2024 Standout
Unraveling the complexity of STAT3 in cancer: molecular understanding and drug discovery
2024 Standout
Works of Jung-Chen Su being referenced
Two novel SHP-1 agonists, SC-43 and SC-78, are more potent than regorafenib in suppressing the in vitro stemness of human colorectal cancer cells
2018
Alteration of SHP-1/p-STAT3 Signaling: A Potential Target for Anticancer Therapy
2017
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Jung-Chen Su | 432 | 245 | 67 | 118 | 26 | 691 | |
| Aaron M. Sargeant | 468 | 128 | 85 | 103 | 30 | 808 | |
| Li-Yuan Bai | 459 | 147 | 81 | 99 | 42 | 846 | |
| Sharavan Ramachandran | 451 | 205 | 31 | 110 | 20 | 817 | |
| Iram Fatima | 322 | 138 | 71 | 56 | 32 | 756 | |
| Noel R. Monks | 330 | 214 | 38 | 73 | 33 | 757 | |
| Walter Bardenheuer | 505 | 292 | 38 | 93 | 37 | 831 | |
| Sumeer Dhar | 442 | 271 | 70 | 65 | 27 | 764 | |
| Chi Hin Cho | 370 | 172 | 26 | 119 | 17 | 744 | |
| Peng Lyu | 410 | 100 | 34 | 67 | 29 | 730 | |
| Olivia Aranha | 389 | 211 | 126 | 39 | 33 | 656 |
All Works
Login with ORCID to disown or claim papers
Loading papers...